on 16 Jan 2018
Last Applicant/ Owned by
3200 Walnut Street
Boulder
CO
80301
Serial Number
87059929 filed on 03rd Jun 2016
Registration Number
5381495 registered on 16th Jan 2018
Filing Basis
1. intent to use
2. use application currently
Disclaimer
"BINIMETINIB"
"BINIMETINIB" Color is not claimed as a feature of the mark. Anti-infectives; Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical preparations acting on the central nerRead More
Anti-infectives; Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the prevention and treatment of cancer and tumors; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma; all of the foregoing incorporating the inhibitor binimetinib
21st Sep 2017
21st Sep 2017
No 87059929
No Service/Collective Mark
No T 428610
No
No
No
No
No
No
No
No
26.01.16 -
Circles touching or intersecting
26.01.21 -
Circles that are totally or partially shaded
26.01.31 -
Five or more circles
The mark consists of the words "MEKTOVI" and below "MEKTOVI" in smaller lettering is the word "(binimetinib)". The upper right of "MEKTOVI" is a series of overlapping circles arranged in a horizontal manner.
| Status Date | Action Taken |
|---|---|
| 16th Jan 2023 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| 04th Jun 2020 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| 04th Jun 2020 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 04th Jun 2020 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 04th Jun 2020 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 04th Jun 2020 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| 16th Jan 2018 | REGISTERED-PRINCIPAL REGISTER |
| 09th Dec 2017 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 08th Dec 2017 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 07th Dec 2017 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
